Skip to main content
. 2015 Sep 22;10(9):e0138054. doi: 10.1371/journal.pone.0138054

Table 1. Histologic Changes Around End of Implant on Post-Operative Day 12.

Treatment Group Fibrosis (Masson’s Trichrome) Cellularity (H&E)
S/B/I + ++
S/I ++ ++
BSS +++ +++
MMC +/- -

S/B/I = Saratin/Bevacizumab/Ilomastat; S/I = Saratin/Ilomastat; BSS = Balanced Saline Solution; MMC = Mitomycin-C;– = absent; +/- = weakly present; +, ++, +++ = present in increasing amounts, as graded by the masked observer.